BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20031839)

  • 1. Knowledge of heart disease risk among SHIELD respondents with dyslipidemia.
    Lewis SJ; Fox KM; Bullano MF; Grandy S;
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):207-12. PubMed ID: 20031839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium.
    Goff DC; Bertoni AG; Kramer H; Bonds D; Blumenthal RS; Tsai MY; Psaty BM
    Circulation; 2006 Feb; 113(5):647-56. PubMed ID: 16461837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes about health and health-related behaviors in patients with cardiovascular disease or at elevated risk for cardiovascular disease.
    Robinson JG; Fox KM; Grandy S;
    Prev Cardiol; 2009; 12(3):136-43. PubMed ID: 19523056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular secondary prevention: patients' knowledge of cardiovascular risk factors and their attitude to reduce the risk burden, and the practice of family doctors. The "Help Your Heart Stay Young" study.
    Celentano A; Palmieri V; Arezzi E; Sabatella M; Guillaro B; Brancati C; Piccinocchi G; Minichiello S; Russo C; Pezzullo S; Tufano A; Finelli L; Panico S; Di Minno G
    Ital Heart J; 2004 Oct; 5(10):767-73. PubMed ID: 15626274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
    Petrella RJ; Merikle E; Jones J
    Clin Ther; 2007 Apr; 29(4):742-50. PubMed ID: 17617298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related behaviours of people with diabetes and those with cardiometabolic risk factors: results from SHIELD.
    Green AJ; Bazata DD; Fox KM; Grandy S;
    Int J Clin Pract; 2007 Nov; 61(11):1791-7. PubMed ID: 17887992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of multiple cardiac risk factors in US adults with diabetes.
    McCollum M; Ellis SL; Morrato EH; Sullivan PW
    Curr Med Res Opin; 2006 Jun; 22(6):1031-4. PubMed ID: 16846537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.
    Grover SA; Lowensteyn I; Joseph L; Kaouache M; Marchand S; Coupal L; Boudreau G;
    Arch Intern Med; 2007 Nov; 167(21):2296-303. PubMed ID: 18039987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary risk factors in adolescents related to their knowledge of familial coronary heart disease and hypercholesterolemia: the Muscatine Study.
    Muhonen LE; Burns TL; Nelson RP; Lauer RM
    Pediatrics; 1994 Mar; 93(3):444-51. PubMed ID: 8115204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding of endocarditis risk improves compliance with prophylaxis.
    Barreira JL; Baptista MJ; Moreira J; Azevedo A; Areias JC
    Rev Port Cardiol; 2002 Sep; 21(9):939-51. PubMed ID: 12416268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.